| abstract |
The present invention provides a method for identifying and confirming neoplasia in the prostate epithelium, a method for measuring the possibility of tumor metastasis, and a method for suppressing or preventing cancer metastasis. Inhibiting uteroglobin, a second therapeutic agent, and a carrier for therapeutically effective administration of a pharmaceutical composition to a living body, wherein the second therapeutic agent inhibits a non-steroidal anti-inflammatory agent, phospholipase A2. The above pharmaceutical composition selected from the group consisting of an agent and an inhibitor of cyclooxygenase. [Selection] Figure 1 |